Pediatric Brain Tumors: Genomics and Epigenomics Pave the Way.

Abstract

Primary malignant brain tumors remain a disproportionate cause of morbidity and mortality in humans. A number of studies exploring the cancer genome of brain tumors across ages using integrated genetics and epigenetics and next-generation sequencing technologies have recently emerged. This has led to considerable advances in the understanding of the basic biology and pathogenesis of brain tumors, including the most malignant and common variants in children: gliomas and medulloblastoma. Notably, studies of pediatric brain tumors have identified unexpected oncogenic pathways implicated in tumorigenesis. These range from a single pathway/molecule defect such as abnormalities of the mitogen-activated protein kinase pathway, considered to be a hallmark of pilocytic astrocytomas, to alterations in the epigenome as a critical component altered in many subgroups of high-grade brain tumors. Importantly, the type, timing, and spatial clustering of these molecular alterations provide a better understanding of the pathogenesis of the respective brain tumor they target and critical markers for therapy that will help refine pathological grading. We summarize these novel findings in pediatric brain tumors, which also are put in the context of the evolving notion of molecular pathology, now a mandated tool for proper classification and therapy assignment in the clinical setting.

• Authors: Adam M Fontebasso, Nada Jabado
• Journal: Critical reviews in oncogenesis (Crit Rev Oncog) Vol. 20 Issue 3-4 Pg. 271-99 ( 2015) ISSN: 0893-9675 [Print] United States
• PMID: 26349420 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Topics

• Animals
• Brain Neoplasms (diagnosis, genetics, therapy)
• Child
• Epigenomics (methods, trends)
• Genomics (methods, trends)
• Glioma (diagnosis, genetics, therapy)
• Humans
• Neural Stem Cells (pathology)